• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经调节蛋白-4:一种通过ErbB-4受体酪氨酸激酶发挥作用的新型生长因子。

Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase.

作者信息

Harari D, Tzahar E, Romano J, Shelly M, Pierce J H, Andrews G C, Yarden Y

机构信息

Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel.

出版信息

Oncogene. 1999 Apr 29;18(17):2681-9. doi: 10.1038/sj.onc.1202631.

DOI:10.1038/sj.onc.1202631
PMID:10348342
Abstract

The ErbB/HER family of receptor tyrosine kinases consists of four receptors that bind a large number of growth factor ligands sharing an epidermal growth factor- (EGF)-like motif. Whereas ErbB-1 binds seven different ligands whose prototype is EGF, the three families of neuregulins (NRGs) activate ErbB-3 and/or ErbB-4. Here we characterize a fourth neuregulin, NRG-4, that acts through ErbB-4. The predicted pro-NRG-4 is a transmembrane protein carrying a unique EGF-like motif and a short cytoplasmic domain. A synthetic peptide encompassing the full-length EGF-like domain can induce growth of interleukin-dependent cells ectopically expressing ErbB-4, but not cells expressing the other three ErbB proteins or their combinations. Consistent with specificity to ErbB-4, NRG-4 can displace an ErbB-4-bound NRG-1 and can activate signaling downstream of this receptor. Expression of NRG-4 mRNA was detected in the adult pancreas and weakly in muscle; other tissues displayed no detectable NRG-4 mRNA. The primary structure and the pattern of expression of NRG-4, together with the strict specificity of this growth factor to ErbB-4, suggest a physiological role distinct from that of the known ErbB ligands.

摘要

受体酪氨酸激酶的ErbB/HER家族由四种受体组成,这些受体可结合大量具有表皮生长因子(EGF)样基序的生长因子配体。ErbB-1可结合七种不同的配体,其原型为EGF,而神经调节蛋白(NRG)的三个家族可激活ErbB-3和/或ErbB-4。在此,我们鉴定了一种通过ErbB-4起作用的第四种神经调节蛋白NRG-4。预测的前体NRG-4是一种跨膜蛋白,带有独特的EGF样基序和一个短的胞质结构域。包含全长EGF样结构域的合成肽可诱导异位表达ErbB-4的白细胞介素依赖性细胞生长,但不能诱导表达其他三种ErbB蛋白或其组合的细胞生长。与对ErbB-4的特异性一致,NRG-4可取代与ErbB-4结合的NRG-1,并可激活该受体下游的信号传导。在成年胰腺中检测到NRG-4 mRNA的表达,在肌肉中表达较弱;其他组织未检测到NRG-4 mRNA。NRG-4的一级结构和表达模式,以及这种生长因子对ErbB-4的严格特异性,提示其生理作用不同于已知的ErbB配体。

相似文献

1
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase.神经调节蛋白-4:一种通过ErbB-4受体酪氨酸激酶发挥作用的新型生长因子。
Oncogene. 1999 Apr 29;18(17):2681-9. doi: 10.1038/sj.onc.1202631.
2
Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.β细胞ulin激活表皮生长因子受体和erbB-4,并诱导出与表皮生长因子或神经调节蛋白-β刺激所产生的不同的细胞反应模式。
Oncogene. 1996 Jan 18;12(2):345-53.
3
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.神经调节蛋白-2,一种ErbB3/ErbB4受体酪氨酸激酶的新配体。
Nature. 1997 May 29;387(6632):512-6. doi: 10.1038/387512a0.
4
A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.一种含有两个卵泡抑素模块的新型表皮生长因子样分子可刺激MKN28胃癌细胞中erbB-4的酪氨酸磷酸化。
Biochem Biophys Res Commun. 1999 Dec 20;266(2):593-602. doi: 10.1006/bbrc.1999.1873.
5
A cysteine-rich form of Xenopus neuregulin induces the expression of acetylcholine receptors in cultured myotubes.非洲爪蟾神经调节蛋白的一种富含半胱氨酸的形式可诱导培养的肌管中乙酰胆碱受体的表达。
Mol Cell Neurosci. 1999 Jun;13(6):415-29. doi: 10.1006/mcne.1999.0759.
6
Molecular cloning, tissue-specific expression, and chromosomal localization of a novel nerve growth factor-regulated G-protein- coupled receptor, nrg-1.一种新型神经生长因子调节的G蛋白偶联受体nrg-1的分子克隆、组织特异性表达及染色体定位
Mol Cell Neurosci. 1999 Aug;14(2):141-52. doi: 10.1006/mcne.1999.0776.
7
Ligands for ErbB-family receptors encoded by a neuregulin-like gene.由神经调节蛋白样基因编码的ErbB家族受体的配体。
Nature. 1997 May 29;387(6632):509-12. doi: 10.1038/387509a0.
8
ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture.表皮生长因子受体(ErbB)信号通路调控胚胎器官培养中发育的胰岛细胞的谱系决定。
Endocrinology. 2002 Nov;143(11):4437-46. doi: 10.1210/en.2002-220382.
9
Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.在有丝分裂期间,神经分化因子/神经调节蛋白可有效诱导p185erbB - 2和erbB - 3募集磷脂酰肌醇3 -激酶,并且在具有c - erbB - 2基因扩增的不依赖生长因子的乳腺癌细胞中,该过程持续增强。
Cell Growth Differ. 1996 May;7(5):551-61.
10
Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.神经调节蛋白-1/表皮生长因子受体(ErbB)信号通路的组成性激活对于一种肿瘤性雪旺细胞系的增殖至关重要。
Glia. 2003 Aug;43(2):104-18. doi: 10.1002/glia.10232.

引用本文的文献

1
Asprosin and Neuregulin 4 in Obesity in Children.儿童肥胖中的阿朴脂蛋白和神经调节蛋白4
Medicina (Kaunas). 2025 Apr 14;61(4):723. doi: 10.3390/medicina61040723.
2
Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside.治疗代谢功能障碍相关脂肪性肝病的分泌蛋白:从 bench 到 bedside
Protein Cell. 2025 Aug 7;16(8):641-666. doi: 10.1093/procel/pwaf027.
3
Adipokines as Cardioprotective Factors: BAT Steps Up to the Plate.脂肪因子作为心脏保护因子:棕色脂肪组织挺身而出。
Biomedicines. 2025 Mar 13;13(3):710. doi: 10.3390/biomedicines13030710.
4
Discovery of NRG1-VII: the myeloid-derived class of NRG1.发现 NRG1-VII:NRG1 的髓系类。
BMC Genomics. 2024 Aug 29;25(1):814. doi: 10.1186/s12864-024-10723-2.
5
Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases.代谢疾病发生过程中新型的葡萄糖和脂质代谢分泌调节因子。
Diabetologia. 2024 Dec;67(12):2626-2636. doi: 10.1007/s00125-024-06253-x. Epub 2024 Aug 24.
6
Low circulating levels of neuregulin 4 as a potential biomarker associated with the severity and prognosis of obesity-related metabolic diseases: a systematic review.神经调节蛋白 4 水平降低作为与肥胖相关代谢性疾病严重程度和预后相关的潜在生物标志物:系统评价。
Adipocyte. 2024 Dec;13(1):2390833. doi: 10.1080/21623945.2024.2390833. Epub 2024 Aug 20.
7
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models.在临床前模型中,ALK抑制剂可抑制肝癌,并与抗PD-1疗法和ABT-263协同作用。
iScience. 2024 Apr 23;27(5):109800. doi: 10.1016/j.isci.2024.109800. eCollection 2024 May 17.
8
The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer.一氧化氮对癌症中HER家族翻译后修饰及下游信号传导的影响。
Front Physiol. 2024 Mar 27;15:1358850. doi: 10.3389/fphys.2024.1358850. eCollection 2024.
9
Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications.靶向 EGFR 的抑制剂:结构、生物学、生物标志物和临床应用。
Cells. 2023 Dec 25;13(1):47. doi: 10.3390/cells13010047.
10
Implications of the Serum Concentrations of Neuregulin-4 (Nrg4) in Patients with Coronary Artery Disease: A Case-Control Study.冠心病患者血清神经调节蛋白4(Nrg4)浓度的意义:一项病例对照研究。
J Tehran Heart Cent. 2023 Jul;18(3):170-176. doi: 10.18502/jthc.v18i3.14111.